CNS Pharmaceuticals, Inc.
CNSP
5 insider filings · Latest: Aug 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Aug 18 1:01 PM | Michal FisherDirector | Purchase | 2,000 | $5.00 | $10.0K | 2,000(D) | View → |
| May 18, 2026 | May 20 1:03 PM | Faith L. CharlesDirector | Purchase | 7,100 | $4.79 | $34.0K | 7,100(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Aug 18 1:00 PM | Rami LevinCEO and President | Option Exercise | 4,750 | — | 14,250(D) | View → |
| Mar 2, 2026 | Mar 4 10:02 PM | Eric FaulknerChief Technology Officer | Grant/Award | 9,500 | — | 9,500(D) | View → |
| Mar 2, 2026 | Mar 4 10:01 PM | Steve O'LoughlinChief Financial Officer | Grant/Award | 9,500 | — | 9,500(D) | View → |